HERBAL SUPPLEMENTS: A POTENTIAL FOR DRUG INTERACTIONS IN TRANSPLANT RECIPIENTS
- 1 January 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 71 (2) , 239-241
- https://doi.org/10.1097/00007890-200101270-00012
Abstract
Herbal dietary supplements represent a potential and possibly an overlooked cause for drug interactions in transplant recipients. Two patients are reported which suggest that St. John’s Wort (SJW) may induce cytochrome P-450 3A4 activity and/or P-glycoprotein expression. Both of these mechanisms are significantly involved in the metabolism and absorption of cyclosporine (CSA) and other immunosuppressants. After two renal transplant recipients started self-medicating with SJW, their CSA concentrations were consistently documented to be subtherapeutic. While on SJW, one patient developed acute graft rejection due to low CSA concentrations. In both patients, termination of SJW returned their CSA concentrations to therapeutic values. Patients taking SJW concomitantly with CSA or other medications whose absorption and metabolism are mediated by cytochrome P-450 and/or P-glycoprotein should require close monitoring. Potential herb-prescription drug interactions are not just limited to SJW. Inquiries regarding the usage of herbal supplements should be an integral component of a transplant recipient’s medication history.Keywords
This publication has 9 references indexed in Scilit:
- Indinavir concentrations and St John's wortThe Lancet, 2000
- Acute heart transplant rejection due to Saint John's wortThe Lancet, 2000
- Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)*1Clinical Pharmacology & Therapeutics, 1999
- Potential Metabolic Interaction between St. John's Wort and TheophyllineAnnals of Pharmacotherapy, 1999
- Unsafe and potentially safe herbal therapiesAmerican Journal of Health-System Pharmacy, 1999
- Herbal MedicinalsArchives of internal medicine (1960), 1998
- Survey of alternative medicine use among organ transplant patientsJournal of Transplant Coordination, 1997
- Drug interactions in transplantationClinical Therapeutics, 1995
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981